DOMS Industries (DOMS) Q3 24/25 earnings summary

Executive summary

• Achieved strong revenue and profit growth in Q3 and 9M FY25, with consolidated operating revenue up 35% YoY for Q3 and 23.9% YoY for 9M, driven by expansion in stationery, art materials, and new product launches.

• PAT increased 40% YoY in Q3 and 43.9% YoY for 9M, reflecting robust operational performance.

• Uniclan Healthcare contributed positively, with new diaper production line installed, increasing capacity and co-branded product launches.

• Awarded Top Exporter Award for the third consecutive year by the Pen & Stationery Association of India.

• Launched ESOPs for over 900 employees and installed a 1MW solar plant to promote sustainability.

Financial highlights

• Q3 FY25 consolidated operating revenue: INR 501.1 crore, up 35% YoY; 9M FY25: INR 1,403.9 crore, up 23.9% YoY.

• Q3 FY25 EBITDA: INR 87.9 crore, up 26.7% YoY; EBITDA margin at 17.5%; 9M FY25 EBITDA: INR 260.2 crore, up 32.2% YoY.

• Q3 FY25 PAT: INR 54.3 crore, up 40% YoY; 9M FY25 PAT: INR 162.3 crore, up 43.9% YoY.

• Gross profit margin for Q3 FY25 at 43.5%.

• Comparable revenue growth (excluding Uniclan): 21.4% for Q3 YoY.

Outlook and guidance

• Maintains full-year consolidated revenue growth target of 23%-25%, including Uniclan.

• EBITDA margin guidance remains at 16%-17% due to Uniclan's lower margins and ESOP/capacity addition costs.

• Ongoing capacity expansion with 44+ acre greenfield project on track; first building for machinery installation expected in Q3 FY26.

• Cautiously optimistic on demand, expecting tailwinds from back-to-school season and government spending.

• FY26 guidance to be finalized post-March business planning.